Mersana Therapeutics, Inc. (31) | Business Finance (12)

Browse by Subcategory

Recent Contracts

First Amendment to Loan and Security Agreement, dated February 17, 2022, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bank, and the Company (Filed With SEC on May 9, 2022)
Form of Inducement Restricted Stock (Filed With SEC on February 28, 2022)
Underwriting Agreement, dated May 28, 2020, among Mersana Therapeutics, Inc. and Cowen and Company, LLC and SVB Leerink LLC, as representatives of the several underwriters listed... (Filed With SEC on June 1, 2020)
Form of Exchange Warrant (Filed With SEC on November 27, 2019)
Exchange Agreement between Mersana Therapeutics, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated... (Filed With SEC on November 27, 2019)
Loan and Security Agreement, dated October 29, 2021, by and between Oxford Finance LLC, Silicon Valley Bank and Mersana Therapeutics, Inc (Filed With SEC on February 28, 2022)
Second Amendment to Loan and Security Agreement, dated August 28, 2020, by and between Mersana Therapeutics, Inc, and Silicon Valley Bank (Filed With SEC on September 3, 2020)
Description of Registrants Common Stock (Filed With SEC on February 28, 2020)
Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on August 8, 2019)
First Amendment to Loan and Security Agreement, dated June 21, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on August 8, 2019)
Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on May 9, 2019)
Underwriting Agreement, dated February 28, 2019, by and among Mersana Therapeutics, Inc. and SVB Leerink LLC, as the representative of the several underwriters listed on Schedule... (Filed With SEC on March 4, 2019)